Boyer David W. bought NBIX
February 12, 2025 · Form 4 insider transaction
Boyer David W. bought 34,153 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
34,153
Price
$0.00
Total value
N/A
InsiderBoyer David W.
Role—
SecurityStock Option
Transaction codeA: Grant or award
Transaction dateFebruary 12, 2025
Filing dateFebruary 14, 2025
Shares owned after34,153
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 12, 2025 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.